ProfileGDS5678 / 1443566_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 31% 21% 21% 20% 20% 22% 21% 21% 20% 21% 21% 22% 31% 21% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.7263331
GSM967853U87-EV human glioblastoma xenograft - Control 22.485621
GSM967854U87-EV human glioblastoma xenograft - Control 32.4917821
GSM967855U87-EV human glioblastoma xenograft - Control 42.4305520
GSM967856U87-EV human glioblastoma xenograft - Control 52.4247620
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5764722
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.5232921
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.480421
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4501620
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4903921
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.476821
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4838522
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.7018531
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4992221